17.12.24
Tuesday 9 February 2021
The Keynes Fund, based at the Faculty of Economics at the University of Cambridge, has a new Deputy Director. St Catharine's Fellow Dr Sriya Iyer (2000) has been appointed for a five-year assignment.
"I'm delighted by this appointment. Sriya will be a very capable Deputy Director, and I look forward to working with her over the next five years,” says Dr Toke Aidt, a University Reader and Director of the Keynes Fund at the Faculty of Economics, University of Cambridge.
The goal of the Fund is to promote quality research in economics and finance in Cambridge, with special emphasis on understanding key distortions that affect market allocations and create inefficiencies.
“The Keynes Fund provides funding for early stage, cutting-edge research in Economics, and I have no doubt that with Sriya on board, we will be able promote top level applied research and create positive externalities for the Cambridge research environment, especially with regard to the promotion of young talent in the Cambridge PhD programme, or among post-docs,” added Dr Aidt.
Dr Sriya Iyer, a University Reader in Economics, herself received a PhD from the University of Cambridge in 2000. She has served on the Board of Directors of the Association for the Study of Religion, Economics and Culture. She is also a Research Fellow at the Center for Economic Policy Research (CEPR) and the Institute for the Study of Labor (IZA).
The Keynes Fund has firmly established its presence in Cambridge. Most of the proposals for funding are from economists in the Faculty and the Judge Business School, but it also has a significant presence of proposals by social historians, lawyers and mathematicians with an interest in finance.
“I am grateful and delighted to take up this position,” says Dr Iyer. “I appreciate the enormous contribution the Keynes Fund makes to those researching economics and finance. I look forward very much to working with Dr Aidt and others at the Keynes Fund to help build Cambridge’s research capability in economics and finance for the future.”
